New technologies and adaptations of existing technologies can improve platform processes.
Jay Wealand
Advertisement
Jay Wealand is a principal scientist at Pfizer BioTherapeutics Research and Development
Articles by Jay Wealand
Advertisement
Latest Updated Articles
Advances in Monoclonal Antibody PurificationMarch 2nd 2010
Advertisement
Advertisement